Exploring Psilocybe spp. mycelium and fruiting body chemistry for potential therapeutic compounds
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Psilocybe mushrooms, otherwise known as “magic” mushrooms, owe their psychedelic effect to psilocin, a serotonin subtype 2A (5-HT 2A) receptor agonist and metabolite of psilocybin, the primary indole alkaloid found in Psilocybe species. Metabolomics is an advanced fingerprinting tool that can be utilized to identify the differences among fungal life stages that may otherwise be unaccounted for. In this study, by using targeted and untargeted (metabolomic) multivariate analysis, we demonstrate that the chemical composition of Psilocybe differs among mycelia, grain mycelia, and fruiting bodies. The preferential accumulation of psilocybin, baeocystin, tryptophan, ergothioneine, and phenylethylamine in fruiting bodies differentiated them from mycelia; however, the levels of alpha-glycerylphosphorylcholine (α-GPC), N-acetylglucosamine, and trimethylglycine were found to be proportionally higher in mycelia than in fruiting bodies based on Pareto-scaled data. Considering the wealth of compounds with therapeutic potential that have been isolated from various fungal genera, it would be pertinent to study the compounds found in Psilocybe mycelia as potential naturally derived therapeutic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cannabidiol is a negative allosteric modulator of the cannabinoid CB 1 receptor
Laprairie, R. B., Bagher, A. M., Kelly, M. E. M., & Denovan‐Wright, E. M. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13250 · Cited by 1,039 · cited 1×
“This may be similar to the relationship between D 9 -tetrahydrocannabinol (THC) and cannabidiol (CBD) from Cannabis , where CBD is a negative allosteric modulator of THC at the cannabinoid receptor 1 (Laprairie et al., 2015).”
BackgroundFungal β-Glucans and Mammalian Immunity
Brown, G. D., & Gordon, S. (2003) · Immunity · doi:10.1016/s1074-7613(03)00233-4 · Cited by 665
Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus
Mygind, P. H., Fischer, R. L., Schnorr, K. M., Hansen, M. T., Sönksen, C. P., Ludvigsen, S., Raventós, D., Buskov, S., Christensen, B., De Maria, L., et al. (2005) · Nature · doi:10.1038/nature04051 · Cited by 657
The clinical significance of betaine, an osmolyte with a key role in methyl group metabolism
Lever, M., & Slow, S. (2010) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2010.03.009 · Cited by 460
Hasler, F., Grimberg, U., Benz, M. A., Huber, T., & Vollenweider, F. X. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1640-6 · Cited by 451
N-Acetylglucosamine: Production and Applications
Chen, J.-K., Shen, C.-R., & Liu, C.-L. (2010) · Marine Drugs · doi:10.3390/md8092493 · Cited by 386
Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
Rickli, A., Moning, O. D., Hoener, M. C., & Liechti, M. E. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.05.001 · Cited by 379
Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways
López-Giménez, J. F., & González-Maeso, J. (2017) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2017_478 · Cited by 299
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232
Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance
Dinis-Oliveira, R. J. (2017) · Drug Metabolism Reviews · doi:10.1080/03602532.2016.1278228 · Cited by 224 · cited 2×
“On oral administration in humans, psilocybin is rapidly converted to psilocin via intestinal alkaline phosphatase, where nearly 100% of the bioactive molecule is found in circulation 30 min to 6 h after ingestion (Dinis-Oliveira, 2017).”
Background
Research works printed but not linked: 2
- López-Giménez, 2018, Hallucinogens receptor-mediated and serotonin signaling 5-HT pathways, Behav. Neurobiol. Psychedelic Drugs, 36, 45, 10.1007/7854_2017_478 · DOI · Paper page
- Wieczorek, 2015, Chapter 5 - bioactive alkaloids of hallucinogenic mushrooms, 133
Cited by
Kurzbaum, E., Páleníček, T., Sharchaton, A., Azerrad, S., & Dekel, Y. (2025) · Journal of Fungi · doi:10.3390/jof11020099 · Cited by 15
Galdino, T. P., Oliveira, L. C., Luz, M. A., Jesus, R. A., Lima, E. P. N., Torres, M. C. M., Sivieri, K., Afonso, V. I., Delgado, J. M. P. Q., Lima, A. G. B., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18030380 · Cited by 12
Sharchaton, A., Parsha, S., Azerrad, S. P., Dekel, Y., Rabah, N., Páleníček, T., & Kurzbaum, E. (2026) · Journal of Fungi · doi:10.3390/jof12070486 · Cited by 1
“In addition, the study by [27,29] showed that fruiting body material and mycelial material differ not only in absolute alkaloid concentration but https://doi.org/10.3390/jof12070486 also in overall metabolite composition, reinforcing the view that developmental stage is a major determinant of…”
Influential
Metadata
- Authors
- Waldbillig, A., Baranova, M., Neumann, S., Andrade, J., & Sidhu, S.
- Corresponding author
- Waldbillig, Adam
- Andrade, Jonathan
- Sidhu, Sharan
- Venue
- Frontiers in Fungal Biology
- Publisher
- Frontiers Media SA
- Published
- 2023-11-29
- Volume
- 4
- Pages
- 1295223-1295223
- ISSN
- 2673-6128 (ISSN-L)
- PMC
- PMC10716206
- OpenAlex
- W4389150740
- Cited by
- 13
- References
- 53
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 3
- FWCI
- 3.78
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Fungal Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Health Sciences › Medicine › Pharmacology (medical) › Fungal Biology and Applications
- Keywords
- Psilocybe, mycelium, fruiting bodies, metabolomics, psilocybin, psilocin, tryptophan, ergothioneine, phenylethylamine, N-acetylglucosamine, betaine, therapeutic compounds, indole alkaloids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Exploring Psilocybe spp. mycelium and fruiting body chemistry for potential therapeutic compounds. https://app.cochat.ai/papers/10.3389/ffunb.2023.1295223
- The paper
- Waldbillig, A., Baranova, M., Neumann, S., Andrade, J., & Sidhu, S. (2023). Exploring Psilocybe spp. mycelium and fruiting body chemistry for potential therapeutic compounds. Frontiers in Fungal Biology. https://doi.org/10.3389/ffunb.2023.1295223
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.